BlackRock’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $227M | Buy |
|
|||||
|
2023
Q3 | $116M | Buy |
|
|||||
|
2023
Q2 | $82.2M | Buy |
|
|||||
|
2023
Q1 | $23.1M | Buy |
|
|||||
|
2022
Q4 | $12.6M | Buy |
|
|||||
|
2022
Q3 | $6.81M | Sell |
|
|||||
|
2022
Q2 | $5.76M | Sell |
|
|||||
|
2022
Q1 | $17M | Buy |
|
|||||
|
2021
Q4 | $18M | Buy |
|
|||||
|
2021
Q3 | $19M | Sell |
|
|||||
|
2021
Q2 | $23.7M | Sell |
|
|||||
|
2021
Q1 | $27.1M | Buy |
|
|||||
|
2020
Q4 | $30.9M | Buy |
|
|||||
|
2020
Q3 | $37.1M | Sell |
|
|||||
|
2020
Q2 | $19.6M | Buy |
|
|||||
|
2020
Q1 | $8.19M | Sell |
|
|||||
|
2019
Q4 | $11M | Sell |
|
|||||
|
2019
Q3 | $28.8M | Buy |
|
|||||
|
2019
Q2 | $39.6M | Buy |
|
|||||
|
2019
Q1 | $66.9M | Sell |
|
|||||
|
2018
Q4 | $40.6M | Buy |
|
|||||
|
2018
Q3 | $49.2M | Buy |
|
|||||
|
2018
Q2 | $54.4M | Buy |
|
|||||
|
2018
Q1 | $15.2M | Buy |
|
|||||
|
2017
Q4 | $6.35M | Buy |
|
|||||
|
2017
Q3 | $4.94M | Buy |
|
|||||
|
2017
Q2 | $1.04M | Buy |
|
|||||
|
2017
Q1 | $513K | Buy |
|